New contract to ensure a robust vaccine-based intervention against a foreign animal disease threat, IT may be necessary to utilize more than one innovative platform technology. To develop and assess…

Ended Definitive Contract Awarded Last action

Contract number
70RSAT20CB0000001
Awardee
Awarding agency
Obligated
$915,706

Award facts

Contract value 100% obligated
$915,706.14 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Science and Technology Directorate Department of Homeland Security
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Firm Fixed Price
Place of performance
Berkeley Lake, GA 30096, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · DE-obligation and closeout -$58,794
Original award $974,500

About this award

This federal contract was awarded to Boehringer Ingelheim Animal Health USA Inc., doing business as Boehringer Ingelheim Vetmedica Inc., by the Department of Homeland Security Science and Technology Directorate. The $915,706.14 firm fixed price contract is for the development and assessment of a single-injection, heterologous vaccine-based intervention against a foreign animal disease threat. The contract aims to ensure a robust vaccine-based solution to address this disease risk. No set-aside designation was used for this award. Boehringer Ingelheim Animal Health USA Inc. is a for-profit manufacturer that has previously received federal contracts and grants from the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) Wildlife Services program to provide oral rabies vaccine baits, wildlife baits, and other products to support wildlife disease prevention efforts.

Description

New contract to ensure a robust vaccine-based intervention against a foreign animal disease threat, IT may be necessary to utilize more than one innovative platform technology. To develop and assess the benefits of a single-injection, heterologous

Quick answers

Who was awarded contract 70RSAT20CB0000001?

70RSAT20CB0000001 was awarded to Boehringer Ingelheim Animal Health USA Inc. by Office of Procurement Operations (Department of Homeland Security) on November 8, 2019.

How much is contract 70RSAT20CB0000001 worth?

The government has obligated $915,706 on 70RSAT20CB0000001.

Which agency awarded contract 70RSAT20CB0000001?

Office of Procurement Operations (Department of Homeland Security) awarded 70RSAT20CB0000001, with funding from Science and Technology Directorate (Department of Homeland Security).

Was contract 70RSAT20CB0000001 competed?

The extent of competition for 70RSAT20CB0000001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award